U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1210-2A>C AND CFTR-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 16, 2018
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001826608.1

Allele description [Variation Report for NM_000492.4(CFTR):c.1210-2A>C]

NM_000492.4(CFTR):c.1210-2A>C

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
CFTR-AS1:CFTR antisense RNA 1 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1210-2A>C
Other names:
1342-2A->C
HGVS:
  • NC_000007.14:g.117548639A>C
  • NG_016465.4:g.87856A>C
  • NM_000492.4:c.1210-2A>CMANE SELECT
  • LRG_663t1:c.1210-2A>C
  • LRG_663:g.87856A>C
  • NC_000007.13:g.117188693A>C
  • NM_000492.3:c.1210-2A>C
Links:
dbSNP: rs397508179
NCBI 1000 Genomes Browser:
rs397508179
Molecular consequence:
  • NM_000492.4:c.1210-2A>C - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
CFTR-related disorder (CFTR-RD)
Synonyms:
CFTR-related disorders; CFTR-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002080560Natera, Inc.
no assertion criteria provided
Pathogenic
(Nov 16, 2018)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002080560.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024